The neurodiagnostics market consists of devices and tests that are used to identify various neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, cancer, stroke, and epilepsy. Imaging tests such as MRI (Magnetic Resonance Imaging) and CT (Computed Tomography) scans provide physicians with detailed images of the brain and spinal cord. Neurological biomarkers testing identifies molecular and genetic markers associated with neurological conditions. Neurological monitoring devices aid in detecting brain activity during neurological procedures. The neurodiagnostics market helps physicians accurately diagnose neurological disorders and aids in the clinical management and treatment of patients.
The Global Neurodiagnostics Market is estimated to be valued at US$ 14.91 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the neurodiagnostics market are Koninklijke Philips N.V, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corporation, Bio-Rad Laboratories Inc., Advanced Brain Monitoring, Inc., Nihon Kohden Corporation, Mitsar Co. LTD., EMS Biomedical, Mennen Medical, Natus Medical Incorporated, Medicaid Systems, Fujirebio, FONAR Corp, ANT Neuro, NEUROLITE AG, and Atlantic Health System. These companies offer advanced imaging systems, neurological monitoring devices, and neurological biomarkers tests for the clinical diagnosis of various neurological disorders.
The growing prevalence of neurological disorders across the world due to increasingly unhealthy lifestyles and an aging global population is expected to drive the demand for Neurodiagnostics Market Demand procedures. According to the World Health Organization, neurological disorders affect over a billion people globally with Alzheimer's disease and dementia being the most common. Increasing healthcare spending on advanced diagnostic technologies to reduce healthcare costs associated with the treatment of chronic neurological conditions will further augment the growth of the neurodiagnostics market.
Global multinational companies are expanding their presence in emerging economies of Asia Pacific, Latin America, and Middle East & Africa to tap the potential opportunities in these untapped markets. Favorable government initiatives to modernize healthcare infrastructure along with health insurance coverage for high-end diagnostic tests are encouraging the adoption of neurodiagnostics services across developing countries.
Market Drivers
Rising geriatric population is a key driver fueling the neurodiagnostics market growth. According to the United Nations, the global population aged 60 years and older is expected to more than double, from 900 million to nearly 2.1 billion between 2015 and 2050. Growing neurological disorders incidence in the elderly population is increasing demand for neurodiagnostics testing for prompt detection and management of neurological conditions.
Impact of Geopolitical Situation on Neurodiagnostics Market Growth
The geopolitical tensions occurring between different countries have negatively impacted the growth of the neurodiagnostics market. Trade restrictions imposed between certain regions have disrupted the supply chain and distribution networks of key neurodiagnostic device manufacturers. Additionally, political instability and ongoing conflicts in regions like Middle East and Asia Pacific have restricted the availability of advanced neurodiagnostic procedures and hindered market expansion opportunities. Device manufacturers now face significant challenges in ensuring steady supply of components and finished products to impacted geographies. They need to consider developing alternative supply sources and distribution channels to negate reliance on conflict-ridden countries. Device localization initiatives may help address import restrictions and foster domestic manufacturing capabilities over the long run.
Geographical Regions with High Market Concentration
North America currently captures the largest share of the global neurodiagnostics market in terms of value. Advanced healthcare infrastructure, rising geriatric population susceptible to neurological disorders, and considerable healthcare spending have propelled the United States to dominate the regional market. Favorable reimbursement policies for diagnostic procedures and wide acceptance of expensive high-end devices further boost the neurodiagnostics industry in the country. Similarly, Western European nations such as Germany, U.K., and France enjoy high market concentration owing to universal health insurance coverage, large patient bases, and growing awareness on early disease detection.
Fastest Growing Regional Market
The Asia Pacific region is poised to emerge as the fastest growing market for neurodiagnostics over the coming years. This can be attributed to increasing prevalence of neurological conditions such as Alzheimer's, Parkinson's, epilepsy, and traumatic brain injuries. Rise in healthcare expenditure by both public and private players, expansion of modern healthcare facilities, and growing geriatric demographics will promote higher adoption of neurodiagnostic solutions. Favorable government policies supporting healthcare infrastructure development along with initiatives to improve access to diagnostic services also boost the regional market. Countries like India, China, Japan, and South Korea are expected to drive the Asia Pacific neurodiagnostics industry owing to their huge patient pools and improving medical technologies penetration.
Get more insights, On Neurodiagnostics Market
Explore Topic on, Neurodiagnostics Market
Comments
0 comment